George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenalytix Plc Regulatory News (RENX)

Share Price Information for Renalytix Plc (RENX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.50
Bid: 24.00
Ask: 25.00
Change: -1.00 (-3.92%)
Spread: 1.00 (4.167%)
Open: 25.50
High: 25.50
Low: 24.50
Prev. Close: 25.50
RENX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Price Monitoring Extn

25 Nov 2020 16:41

RNS Number : 5327G
Renalytix AI PLC
25 November 2020
 

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APMFLFSRLLLEFII
Date   Source Headline
26th Nov 20207:00 amRNSSale of shares in Renalytix AI plc
25th Nov 20204:41 pmRNSSecond Price Monitoring Extn
25th Nov 20204:35 pmRNSPrice Monitoring Extension
25th Nov 20207:00 amRNSFinancial Results for First Quarter of FY 2021
13th Nov 20207:00 amRNSStifel 2020 Healthcare Conference
6th Nov 20207:00 amRNSChange of Adviser
2nd Nov 20203:30 pmRNSPosting of Annual Report & Accounts &Notice of AGM
28th Oct 20202:15 pmRNSRe-issued: EKF marketing & distribution agreement
27th Oct 20207:00 amRNSFull Year Report
20th Oct 202012:00 pmRNSSchedule One - Verici Dx PLC
16th Oct 20207:00 amRNSNotice of Results
13th Oct 20203:32 pmRNSVerici Dx - Intention to admit to trading on AIM
22nd Sep 20207:00 amRNSCalifornia Commercial Lab Certification Recieved
18th Sep 20207:00 amRNSKidneyIntelX clinical testing launch
2nd Sep 20207:00 amRNSGrant of Purchase Rights and Verici update
26th Aug 20207:00 amRNSSubmission seeking FDA Clearance of KidneyIntelX
21st Aug 20208:00 amRNSRenalytixAI to Collaborate with AstraZeneca
3rd Aug 20207:00 amRNSKidneyIntelX in Multi-Center Study
31st Jul 20204:31 pmRNSTotal Voting Rights
27th Jul 20207:00 amRNSOver allotment option exercise
21st Jul 20205:30 pmRNSClosing of Global Offering and resulting TVR
17th Jul 20207:00 amRNSPricing of Global Offering
13th Jul 202012:01 pmRNSLaunch of Global Offering and application to list
13th Jul 202011:45 amRNSResult of General Meeting
8th Jul 20207:01 amRNSApproval of distribution of shares in Verici Dx
8th Jul 20207:00 amRNSPartnership with America’s Choice Provider Network
7th Jul 20207:00 amRNSHolding(s) in Company
1st Jul 20207:00 amRNSKidneyIntelX study accepted for publication
30th Jun 20207:00 amRNSUniversity of Michigan Partnership & Data Sharing
25th Jun 20207:01 amRNSProposed Board changes; Circular & Notice of GM
25th Jun 20207:00 amRNSPublic filing re. Nasdaq dual-listing and offering
12th Jun 20207:00 amRNSKidneyIntelX™ receives New York State approval
10th Jun 20208:00 amRNSConfirmation of reduction of capital
10th Jun 20207:00 amRNSPositive results of clinical validation study
20th May 202011:06 amRNSSecond Price Monitoring Extn
20th May 202011:00 amRNSPrice Monitoring Extension
20th May 20207:00 amRNSJV for COVID-19 antibody test scaled production
18th May 20207:00 amRNSProposed dual-listing on Nasdaq
15th May 20201:02 pmRNSResult of General Meeting
5th May 202010:55 amRNSRemoval of US Securities Law Restrictions
28th Apr 20207:00 amRNSUpdate re. potential demerger of FractalDx
27th Apr 20207:00 amRNSUtah Lab Facility Achieves ISO 13485 Certification
20th Apr 20207:00 amRNSKidneyIntelX used in Mount Sinai COVID-19 study
15th Apr 20207:00 amRNSProvider network agreement for KidneyIntelX™
1st Apr 20207:00 amRNSMedicare provider number
27th Mar 202010:32 amRNSHolding(s) in Company
27th Mar 20207:00 amRNSPresentation of KidneyIntelX Health Economics Data
24th Mar 20207:00 amRNSPodium Presentation and Publication for Data
3rd Mar 20207:00 amRNSHalf-year Report
26th Feb 20207:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.